Donidalorsen Reduces HAE Attacks, Study Shows
Hand swollen during hereditary angioedema attack. Sourced from Wikimedia Commons

Donidalorsen Reduces HAE Attacks, Study Shows

In patients with hereditary angioedema (HAE), the C1-inhibitor blood protein does not function properly, allowing bradykinin peptides to build up in the body. These then cause inflammation and fluid leakage;…

Continue Reading Donidalorsen Reduces HAE Attacks, Study Shows
ERN-RITA Enables Virtual Health Consultations With European Experts
source: pixabay.com

ERN-RITA Enables Virtual Health Consultations With European Experts

Note: this story was originally published by HAE Junior, a Patient Worthy partner Interview with Malena Vetterli from the European Reference Network (ERN-RITA) for rare immunodeficiencies, autoinflammatory and autoimmune diseases.…

Continue Reading ERN-RITA Enables Virtual Health Consultations With European Experts

HAE Junior’s Drawing Exhibition Unveiled the Dreams and Ambitions of Children Living With Hereditary Angioedema

HAE Junior’s drawing exhibition unveiled the dreams, wishes, and ambitions of children & teenagers living with hereditary angioedema (HAE). The patient organization HAE Junior organized a drawing exhibition named We…

Continue Reading HAE Junior’s Drawing Exhibition Unveiled the Dreams and Ambitions of Children Living With Hereditary Angioedema
Experimental Hereditary Angioedema Treatment Performs Well in Phase 2 Trial
source: pixabay.com

Experimental Hereditary Angioedema Treatment Performs Well in Phase 2 Trial

According to a story from PR Newswire, the biotechnology company Ionis Pharmaceuticals recently announced promising findings from its phase 2 clinical trial. This clinical trial was evaluating the company's experimental…

Continue Reading Experimental Hereditary Angioedema Treatment Performs Well in Phase 2 Trial